Similarly, gemcitabine is another candidate drug in the asthma-COPD and its intranasal administration significantly reduces viruses and the inflammation of lungs and the anti-inflammatory cytokines including TNF-α and IL-1b. The gene discussed is TNF; the disease is asthma.